Abstract
Personality traits have been shown to interact with environmental cues to modulate biological responses including treatment responses, and potentially having a role in the formation of placebo effects. Here, we assessed psychological traits in 50 healthy controls as to their capacity to predict placebo analgesic effects, placebo-induced activation of μ-opioid neurotransmission and changes in cortisol plasma levels during a sustained experimental pain challenge (hypertonic saline infused in the masseter muscle) with and without placebo administration. Statistical analyses showed that an aggregate of scores from Ego-Resiliency, NEO Altruism, NEO Straightforwardness (positive predictors) and NEO Angry Hostility (negative predictor) scales accounted for 25% of the variance in placebo analgesic responses. Molecular imaging showed that subjects scoring above the median in a composite of those trait measures also presented greater placebo-induced activation of μ-opioid neurotransmission in the subgenual and dorsal anterior cingulate cortex (ACC), orbitofrontal cortex, insula, nucleus accumbens, amygdala and periaqueductal gray (PAG). Endogenous opioid release in the dorsal ACC and PAG was positively correlated with placebo-induced reductions in pain ratings. Significant reductions in cortisol levels were observed during placebo administration and were positively correlated with decreases in pain ratings, μ-opioid system activation in the dorsal ACC and PAG, and as a trend, negatively with NEO Angry Hostility scores. Our results show that personality traits explain a substantial proportion of the variance in placebo analgesic responses and are further associated with activations in endogenous opioid neurotransmission, and as a trend cortisol plasma levels. This initial data, if replicated in larger sample, suggest that simple trait measures easily deployable in the field could be utilized to reduce variability in clinical trials, but may also point to measures of individual resiliency in the face of aversive stimuli such as persistent pain and potentially other stressors.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C (2006). Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120: 8–15.
Block J, Kremen AM (1996). IQ and ego-resiliency: conceptual and empirical connections and separateness. J Pers Soc Psycol 70: 349–361.
Bruehl S, Burns JW, Chung OY, Chont M (2009). Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms. Neurosci Biobehav Rev 33: 475–491.
Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS et al (2010). Dopaminergic network differences in human impulsivity. Science 329: 532.
Bujdoso E, Jaszberenyi M, Tomboly C, Toth G, Telegdy G (2001). Behavioral and neuroendocrine actions of endomorphin-2. Peptides 22: 1459–1463.
Burns JW, Bruehl S, Chung OY, Magid E, Chont M, Goodlad JK et al (2009). Endogenous opioids may buffer effects of anger arousal on sensitivity to subsequent pain. Pain 146: 276–282.
Carver CS, White TL (1994). Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS Scales. J Pers Soc Psycol 67: 319–333.
Charney DS (2004). Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry 161: 195–216.
Colloca L, Benedetti F (2009). Placebo analgesia induced by social observational learning. Pain 144: 28–34.
Costa P, McRae R (1992a). Normal personality assessment in clinical plactice: the NEO Personality Inventory. Psychol Assessment 4: 5–13.
Costa PT, McCrae RR (1992b) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory professional manual. Psychological Assessment Resources Odessa, FL.
Danziger N, Faillenot I, Peyron R (2009). Can we share a pain we never felt? Neural correlates of empathy in patients with congenital insensitivity to pain. Neuron 61: 203–212.
de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ (2001). Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science 293: 1164–1166.
Feder A, Nestler EJ, Charney DS (2009). Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 10: 446–457.
Fredrickson BL, Tugade MM, Waugh CE, Larkin GR (2003). What good are positive emotions in crises? A prospective study of resilience and emotions following the terrorist attacks on the United States on September 11th, 2001. J Pers Soc Psychol 84: 365–376.
Geers AL, Wellman JA, Fowler SL, Helfer SG, France CR (2010). Dispositional optimism predicts placebo analgesia. J Pain 11: 1165–1171.
Graziano WG, Habashi MM, Sheese BE, Tobin RM (2007). Agreeableness, empathy, and helping: a person x situation perspective. J Pers Soc Psychol 93: 583–599.
Hrobjartsson A, Gotzsche PC (2001). Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344: 1594–1602.
Jackson RV, Grice JE, Jackson AJ, Hockings GI (1990). Naloxone-induced ACTH release in man is inhibited by clonidine. Clin Exp Pharmacol Physiol 17: 179–184.
Kelley JM, Lembo AJ, Ablon JS, Villanueva JJ, Conboy LA, Levy R et al (2009). Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med 71: 789–797.
Keyes CLM (1998). Social well-being. Soc Psychol Quart 61: 121–140.
Kirsch I (1985). Response expectancy as a determinant of experience and behavior. Am Psychol 40: 1189–1202.
Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ et al (2007). Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131: 391–404.
Lasagna L, Mosteller F, Von Felsinger JM, Beecher HK (1954). A study of the placebo response. Am J Med 16: 770–779.
Le Cao KA, Rossouw D, Robert-Granie C, Besse P (2008). A sparse PLS for variable selection when integrating omics data. Stat Appl Genet Mol Biol 7: Article 35.
Leknes S, Tracey I (2008). A common neurobiology for pain and pleasure. Nat Rev Neurosci 9: 314–320.
Liberman R (1962). An analysis of the placebo phenomenon. J Chronic Dis 15: 761–783.
Love TM, Stohler CS, Zubieta JK (2009). Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry 66: 1124–1134.
Mackenbach JP (2005). On the survival of the altruistic trait in medicine: is there a link with the placebo effect? J Clin Epidemiol 58: 433–435.
Maitra S, Yan Y (2008). Principle component analysis and partial least squares: two dimension reduction techniques for regression. CAS Casualty Actuarial Society 2008 Discussion Paper Program.
Martin del Campo AF, Dowson JH, Herbert J, Paykel ES (1994). Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man. Psychopharmacology 114: 583–590.
Melzack R, Torgerson WS (1971). On the language of pain. Anesthesiology 34: 50–59.
Morton DL, Watson A, El-Deredy W, Jones AK (2009). Reproducibility of placebo analgesia: Effect of dispositional optimism. Pain 146: 194–198.
Pavot W, Diener E, Colvin CR, Sandvik E (1991). Further validation of the satisfaction with life scale: evidence for the cross-method convergence of well-being measures. J Pers Assess 57: 149–161.
Quilty LC, De Fruyt F, Rolland JP, Kennedy SH, Rouillon PF, Bagby RM (2008). Dimensional personality traits and treatment outcome in patients with major depressive disorder. J Affect Disord 108: 241–250.
Quilty LC, Sellbom M, Tackett JL, Bagby RM (2009). Personality trait predictors of bipolar disorder symptoms. Psychiatry Res 169: 159–163.
Reske M, Paulus MP (2008). Predicting treatment outcome in stimulant dependence. Ann N Y Acad Sci 1141: 270–283.
Rilling J, Gutman D, Zeh T, Pagnoni G, Berns G, Kilts C (2002). A neural basis for social cooperation. Neuron 35: 395–405.
Scheier MF, Carver CS, Bridges MW (1994). Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 67: 1063–1078.
Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC (2009). The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci 29: 4882–4887.
Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2007). Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55: 325–336.
Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2008). Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 65: 220–231.
Sim LJ, Joseph SA (1991). Arcuate nucleus projections to brainstem regions which modulate nociception. J Chem Neuroanat 4: 97–109.
Spielberg CD (1983) Manual for the State-Trait Anxiety Inventory (Form Y). Consulting Psychologist Press, Inc: Palo Alto.
Vythilingam M, Nelson EE, Scaramozza M, Waldeck T, Hazlett G, Southwick SM et al (2009). Reward circuitry in resilience to severe trauma: an fMRI investigation of resilient special forces soldiers. Psychiatry Res 172: 75–77.
Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ et al (2004). Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303: 1162–1167.
Wager TD, Scott DJ, Zubieta JK (2007). Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci USA 104: 11056–11061.
Watamura SE, Donzella B, Kertes DA, Gunnar MR (2004). Developmental changes in baseline cortisol activity in early childhood: relations with napping and effortful control. Dev Psychobiol 45: 125–133.
Watson D, Clark LA, Tellegen A (1988). Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54: 1063–1070.
Wold H (1966). Estimation fo principal components and related models by iterative least squares. In: Krishnaiah PR, (Ed) Mulitvariate Analysis Academic Press: New York, 39: 1–420.
Wold S, Sjostrom M, Eriksson L (2001). PLS-regression: a basic tool of chemometrics. Chemometr Intell Lab Syst 58: 109–130.
Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R et al (2008). Genetic variation in human NPY expression affects stress response and emotion. Nature 452: 997–1001.
Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA et al (2005). Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 25: 7754–7762.
Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y et al (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299: 1240–1243.
Acknowledgements
Work was supported by R01 AT 001415, R01 DA 016423, R01 DA 022520 (JKZ) and the Phil F. Jenkins Foundation. We would also like to acknowledge the contribution of the technologists of the PET Center at the University of Michigan.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
JKZ received compensation as consultant from Eli Lilly, Johnson & Johnson, Abbot and Merck pharmaceutical during the 3 years prior to manuscript submission for work unrelated to the content of the manuscript. The remaining authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Neuropsychopharmacology website
Supplementary information
Rights and permissions
About this article
Cite this article
Peciña, M., Azhar, H., Love, T. et al. Personality Trait Predictors of Placebo Analgesia and Neurobiological Correlates. Neuropsychopharmacol 38, 639–646 (2013). https://doi.org/10.1038/npp.2012.227
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2012.227
Keywords
This article is cited by
-
Genetic placebo effect on psychological resilience: the moderating role of self-compassion
Current Psychology (2023)
-
Consumer altruism and risk taking: why do altruistic consumers take more risks?
International Review on Public and Nonprofit Marketing (2022)
-
Analgetische Placeboeffekte und Implikationen für die Behandlung chronischer Schmerzen
Psychotherapeut (2022)
-
Neurological and psychological mechanisms of the specific and nonspecific effects of acupuncture on knee osteoarthritis: study protocol for a randomized, controlled, crossover trial
Trials (2020)
-
Naltrexone modulates contextual processing in depression
Neuropsychopharmacology (2020)
